FM

Frazier Management Portfolio holdings

AUM $1.12M
This Quarter Return
+27.43%
1 Year Return
+150.24%
3 Year Return
+430.4%
5 Year Return
+1,926.83%
10 Year Return
–
AUM
$1.3B
AUM Growth
+$1.3B
Cap. Flow
+$96.5M
Cap. Flow %
7.43%
Top 10 Hldgs %
78.61%
Holding
39
New
8
Increased
5
Reduced
4
Closed
4

Top Buys

1
TARS icon
Tarsus Pharmaceuticals
TARS
$79.2M
2
STRO icon
Sutro Biopharma
STRO
$21.7M
3
FLACU
Frazier Lifesciences Acquisition Corporation Unit
FLACU
$15.6M
4
EPZM
Epizyme, Inc
EPZM
$7.94M
5
MTEM
Molecular Templates, Inc.
MTEM
$7.91M

Top Sells

1
ANAB icon
AnaptysBio
ANAB
$30.5M
2
RCKT icon
Rocket Pharmaceuticals
RCKT
$19.7M
3
NBRV
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$9.27M
4
CDTX icon
Cidara Therapeutics
CDTX
$3.74M
5
VTVT icon
vTv Therapeutics
VTVT
$1.88M

Sector Composition

1 Healthcare 95.34%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
ARQT icon
1
Arcutis Biotherapeutics
ARQT
$1.86B
$297M 22.84% 10,542,790 – –
PHAT icon
2
Phathom Pharmaceuticals
PHAT
$864M
$194M 14.91% 5,827,415 – –
PASG icon
3
Passage Bio
PASG
$22.7M
$128M 9.86% 5,009,219 – –
TARS icon
4
Tarsus Pharmaceuticals
TARS
$2.47B
$79.2M 6.1% +1,917,157 New +$79.2M
MIRM icon
5
Mirum Pharmaceuticals
MIRM
$3.71B
$62.3M 4.8% 3,566,912 – –
PCVX icon
6
Vaxcyte
PCVX
$4B
$61.4M 4.73% 2,309,554 – –
IOVA icon
7
Iovance Biotherapeutics
IOVA
$807M
$60.9M 4.69% 1,312,999 – –
KRYS icon
8
Krystal Biotech
KRYS
$4.27B
$53.7M 4.14% 895,000 – –
TRIL
9
DELISTED
Trillium Therapeutics Inc.
TRIL
$44.9M 3.46% 3,053,107 +264,664 +9% +$3.89M
TBIO
10
DELISTED
Translate Bio, Inc. Common Stock
TBIO
$40.2M 3.1% 2,182,789 – –
ALPN
11
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
$32.4M 2.5% 2,571,450 – –
SNDX icon
12
Syndax Pharmaceuticals
SNDX
$1.41B
$31.2M 2.41% 1,405,045 +85,000 +6% +$1.89M
STRO icon
13
Sutro Biopharma
STRO
$72.7M
$21.7M 1.67% +1,001,421 New +$21.7M
ANAB icon
14
AnaptysBio
ANAB
$569M
$19.3M 1.49% 899,700 -1,416,747 -61% -$30.5M
COLL icon
15
Collegium Pharmaceutical
COLL
$1.22B
$18.9M 1.46% 943,666 – –
ISEE
16
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$17.2M 1.33% 2,494,500 +130,000 +5% +$898K
FLACU
17
DELISTED
Frazier Lifesciences Acquisition Corporation Unit
FLACU
$15.6M 1.2% +1,501,000 New +$15.6M
ADVM icon
18
Adverum Biotechnologies
ADVM
$64.6M
$15.6M 1.2% 1,437,028 – –
RGNX icon
19
Regenxbio
RGNX
$451M
$15.5M 1.19% 341,954 +167,754 +96% +$7.61M
APTX
20
DELISTED
Aptinyx Inc. Common Stock
APTX
$11M 0.85% 3,190,079 – –
CRDF icon
21
Cardiff Oncology
CRDF
$140M
$10.2M 0.79% 568,500 +308,500 +119% +$5.55M
FRLN
22
DELISTED
Freeline Therapeutics Holdings plc American Depositary Shares
FRLN
$10M 0.77% 550,000 – –
RCKT icon
23
Rocket Pharmaceuticals
RCKT
$354M
$9.21M 0.71% 168,000 -360,000 -68% -$19.7M
GRTS
24
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$8.12M 0.63% 2,061,758 – –
EPZM
25
DELISTED
Epizyme, Inc
EPZM
$7.94M 0.61% +731,436 New +$7.94M
1
2